DOCUMENT RESOURCES FOR EVERYONE
Documents tagged
Business Plasma therapy training presentation

1. Asahi Kasei MedicalAsahi Kasei Medical Plasma TherapyPlasma Therapy Training ProgrammeTraining Programme 2. Asahi Kasei MedicalAsahi Kasei Medical Biomembrane DialysersBiomembrane…

Health & Medicine Goodpasture Syndrome

G GoodPasture Syndrome â¦named after the American pathologist, Ernest Goodpasture. Introduction⦠Goodpasture syndrome (GPS) also known as Goodpastureâs disease is a…

Documents Csim2.71 – the Patient With Proteinuria and Haematuria

CSIM2.71 â THE PATIENT WITH PROTEINURIA AND HAEMATURIA THEMED WEEK 8: INVESTIGATION OF ABNORMAL RENAL FUNCTION Glomerulonephritis · Inflammatory condition of the glomeruli.…

Documents The immunogenetic mechanism of renal injury George P Lai.

The immunogenetic mechanism of renal injury George P Lai Basic component of renal immune response Humoral response Anti-GBM disease Immune complex disease The cellular response…

Documents Goodpasture's syndrome: An analysis of 29 cases

Goodpasture's syndrome: An analysis of 29 casesGoodpasture's syndrome: An analysis of 29 cases CLINTON A. TEAGUE, PETER B. DOAK, IAN J. SIMPSON, STEPHEN P. RAINER,

Documents ANTI-GBM/GOODPASTURE’S SYNDROME

ANTI-GBM/GOODPASTURE’S SYNDROME Page 1 of 5 Reproduction of this material requires written permission of the Vasculitis Foundation. Copyright 2022. What is anti-GBM/Goodpasture’s

Documents Rituximab for Anti–Glomerular Basement Membrane Disease

Rituximab for Anti-Glomerular Basement Membrane DiseaseRashmi Jain1, Hanna Dgheim2 and Andrew S. Bomback1 1Department of Medicine, Division of Nephrology, Columbia University

Documents Diagnostic and Management Challenges in Goodpasture’s (Anti-GBM) Disease

SR Henderson, AD Salama. Centre for Nephrology, Division of Medicine, University College London, Royal Free Hospital, London, UK UCL Centre for Nephrology No conflicts of

Documents An Open-Label Phase II Study in anti-GBM disease (Goodpasture’s disease) with Adverse Renal...

Februay 13, 2018 1 Study protocol: GOOD-IDES-01, 13 February 2018 An Open-Label Phase II Study in anti-GBM disease (Goodpasture’s disease) with Adverse Renal Prognosis